RecruitingNCT06177717

Deep Functional Phenotyping of the ALA Lung Health Cohort

The American Lung Association (ALA) Deep Phenotyping Ancillary Study of the Lung Health Cohort (LHC)


Sponsor

Johns Hopkins University

Enrollment

1,000 participants

Start Date

Feb 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' airways, * the structure of blood vessels in the participants lungs and heart, and * the participants lungs' ability to exchange gases. Participants will take four different lung function tests to measure lung function, including: * air movement in the lungs (oscillometry) * lung size (slow vital capacity (SVC) and functional residual capacity (FRC) * gas transfer in the lungs (diffusing capacity for carbon monoxide (DLCO).


Eligibility

Min Age: 25 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with lung diseases. The study is currently recruiting participants at 12 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(12)

University of Alabama

Birmingham, Alabama, United States

University of California, Los Angeles

Los Angeles, California, United States

National Jewish Health

Denver, Colorado, United States

Nemours Children's Jacksonville

Jacksonville, Florida, United States

Northwestern University

Chicago, Illinois, United States

University of Kansas

Kansas City, Kansas, United States

Johns Hopkins University

Baltimore, Maryland, United States

University of Michigan

Ann Arbor, Michigan, United States

Duke University

Durham, North Carolina, United States

Wake Forest School of Medicine

Winston-Salem, North Carolina, United States

University of Pittsburgh - Emphysema/COPD Research Center

Pittsburgh, Pennsylvania, United States

University of Vermont

Burlington, Vermont, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06177717


Related Trials